I agree with the information provided below, by paper man! I think we could and should, at least, act like an ally and an active, positive shareholder, of the company, ADVR. But, everyone is entitled to their own opinion, even if it is not a positive one! We will eventually see who is right and who is wrong. Personally, I think the paper man is correct.
<<<Advanced Viral Research Inc. is currently capable of producing an estimated 8 million ampules annually at their current facility! Most importantly, any testing or current sales and of course the current inventory; has been produced in the past three years at the existing facility. The previous aged inventory, that was reported to have a shelf life of 25 to 35 years, is not being used and may or may not have been destroyed.
With a relative investment, that capacity can go to 15 million ampules annually. Of course we need science and approval via ANMAT for sales.
Unless ANMAT decides today that all of a sudden all the work that they have invested into research is of zero value, then I anticipate approval and sales by the end of this year, if not sooner.
For Dr. Hirschman to be quoted by Bloomberg for 1 billion in three years, something tells me that this was the easiest of the research.
good luck<<< |
